Yvonne Kramer

Yvonne Kramer joined Biosyntech, Inc. as Senior Director of Corporate and Business Development in September 2006.
She has 8 years of international experience in the pharmaceutical industry and was a Senior Investment Analyst of MDS Capital.
Dr. Kramer held various positions at Novartis Pharma and joined Novartis Canada as the Head of Basic Research in 2000.
She received a PhD in Immunology from the Basel Institute for Immunology.